Substance / Medication

Efinaconazole

Overview

Active Ingredient
efinaconazole
RxNorm CUI
1539753

Indications

Trichophyton rubrum Trichophyton mentagrophytes JUBLIA (efinaconazole) topical solution, 10% is an azole antifungal indicated for the topical treatment of onychomycosis of the toenail(s) due toand.

Labeler: Bausch Health US LLCUpdated: 2025-07-01T00:00:00.000ZFull label on DailyMed

Contraindications

When this intervention should not be used

None.

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Detailed dosage and administration information is available in the full FDA drug label.

View full prescribing information on DailyMed

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Clinical Trials

4 trials linked to this intervention

4
Total Trials
0
Recruiting
3
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Efficacy of combination therapy with efinaconazole 10% solution and 1064 nm Nd:YAG laser for treatment of toenail onychomycosis.
Bonhert Krista, Dorizas Andrew, Sadick Neil S · J Cosmet Laser Ther · 2019
PMID: 30052090RCT
Determination of Efinaconazole in Plasma using Validated LC-MS/MS Technique.
Srinivasan Govindarajan, Viswambaran Asharani Indira · Drug Metab Bioanal Lett · 2024
PMID: 40296490Observational
Efinaconazole solution 10% for treatment of toenail onychomycosis in Latino patients.
Cook-Bolden Fran E, Lin Tina · Cutis · 2017
PMID: 28492600Observational
Activities of Luliconazole, Lanoconazole, and Efinaconazole Compared with Those of Five Antifungal Drugs against Melanized Fungi and Relatives.
Shokoohi Gholam Reza, Badali Hamid, Mirhendi Hossein et al. · Antimicrob Agents Chemother · 2017
PMID: 28848012ObservationalFull text (PMC)
Efinaconazole topical solution, 10%: the benefits of treating onychomycosis early.
Rich Phoebe · J Drugs Dermatol · 2015
PMID: 25607909Observational
Efinaconazole Topical Solution, 10% Efficacy in Patients with Onychomycosis and Coexisting Tinea Pedis.
Markinson Bryan, Caldwell Bryan · J Am Podiatr Med Assoc · 2015
PMID: 26429609Observational

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Adverse reaction and safety data for this drug is sourced from the FDA-approved label.

View adverse reactions & drug interactions on DailyMed

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Efinaconazole (substance)
SNOMED CT
703880007
UMLS CUI
C3273754
RxNorm CUI
1539753
Labeler
Bausch Health US LLC

Clinical Data

This intervention maps to 2 entities in the Ltrl knowledge graph.

2
Conditions
0
Biomarkers
0
Specialists
0
Symptoms
4
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.